CVS Health (NYSE:CVS) received the 2026 Newsweek AI Impact Award for its AI-driven prescription technology. The company was recognized for AI tools that standardize prescription inputs and support ...

CVS Health Corporation (NYSE:CVS) is one of the 12 Strong Buy Stocks to Buy and Hold for the Next 5 Years. On May 21, 2026, ...

In a reversal from last year, CVS will begin covering Eli Lilly's Zepbound and Foundayo in its standard prescription plan, a ...

The governor went on offense against his Democratic primary challenger after the new 12 News/Emerson poll showed him down by ...

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

CVS Health has announced a significant expansion of its coverage for Eli Lilly's weight-loss medications, confirming it will ...

CVS Health (NYSE:CVS) has launched Aetna Mental Health On Demand to widen access to virtual behavioral health services. The company is expanding its pharmacy benefits with updated GLP-1 formulary ...

CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said.

CVS is adding two weight loss options to its drug plans. They will start coverage of the GLP-1 pill starting June 1, and reinstate coverage of Zepbound Oct. 1.

CVS Health (NYSE: CVS) today announced updates to its most common commercial formularies, expanding GLP-1 options for members— including the reintroduction of Zepbound® (tirzepatide) as a covered ...

Akash Kyal and Rishav Ranjan have been friends for over 15 years. They both graduated from IIT Kharagpur and then from IIM Bangalore.

CVS proposes to cut vocational courses in favor of traditional programs, facing staff backlash for contradicting NEP 2020’s ...